Blog

Now There's a Sports Bra Made Specifically for Breast Cancer Survivors

Because women around the world fight breast cancer every damn day, but many struggle to find the perfect post-mastectomy sports bra once they return to their old fitness routines, Athleta has designed a brand new bra to make women in recovery or remission way more comfortable. Known as the Empower bra ($54 at Athleta.com), it features super-soft fabrics and a front zip that don't aggravate sensitive scar tissue, expanding pockets to secure post-mastectomy prosthetics, and adjustable straps to accommodate for variance in breast size after surgery. To read the rest of the article, click HERE (photo credit: Athleta)

Is it Alzheimer’s disease or another type of dementia? New test differentiates between the two with

A new test differentiates between different types of dementia with up to 90 per cent accuracy, new research reveals. The analysis, which involves placing a coil against a suspected patient's head, can tell the difference between an Alzheimer's disease or frontotemporal dementia sufferer with 90 percent reliability, a new study found. Study author Dr Barbara Borroni, from the University of Brescia in Italy, said: 'Current [diagnosis] methods can be expensive brain scans or invasive lumbar punctures involving a needle inserted in the spine, so it's exciting that we may be able to make the diagnosis quickly and easily with this non-invasive procedure. To read the full article, click HERE (stock

5 New Breast Cancer Treatments That Are Helping to Save Lives

In the fight to end breast cancer, several new drugs are expected to become available soon. Bloomberg Intelligence predicts drug sales to treat the disease could rise to $23 billion by 2021, a 50% gain, because major companies including Eli Lilly & Co. (LLY) , Novartis AG (NVS) and Pfizer Inc. (PFE) are testing new treatments. The latest addition to the spread of treatments is Puma Biotechnology Inc.'s (PBYI) Nerlynx, which is expected to become commercially available in September. The federal Food and Drug Administration approved its use on Monday, July 17. Nerlynx is a once-daily oral inhibitor of an enzyme called tyrosine kinase that can mutate to create the conditions for unregulated ce

New Study Links Poor Sleep Quality with Alzheimer’s Disease

It’s still unclear what causes Alzheimer’s disease, so when new studies show potential connections between lifestyle factors and Alzheimer’s, people often become alarmed. A new study has found a potential correlation between sleep quality and Alzheimer’s, which may leave many insomniacs and poor sleepers feeling nervous. However, doctors are reminding people not to be too afraid of Alzheimer’s just because they tend to sleep poorly. Here’s what you need to know. To read the full article, click HERE Written by Maggie McCracken for Care2.com (http://www.care2.com)

Genetic Testing Underutilized in Early Breast Cancer

Patients with early-stage breast cancer often undergo definitive surgery without genetic testing, or before BRCA1/2 testing has been performed, and the results frequently aren't explained to them, a survey of surgeons and patients found. Approximately one-third of surgeons said they rarely referred patients for genetic counseling, and only 73% of high-volume surgeons and 35% of lower-volume surgeons said they were confident in discussing genetic test results with their patients, reported Allison Kurian, MD, of the Stanford University School of Medicine in California, and colleagues. To read the full article, click HERE Written by Jeff Minerd for MedPage Today (Photo: proimos/Flickr)

Alzheimer's disease set to cost the U.S. $1.1 trillion by 2025

Alzheimer’s disease, the irreversible progressive brain disorder that destroys memory, is set to cost Americans $1.1 trillion by 2025, if we don’t find a solution soon, the Alzheimer’s Association says. “In the last few years, we have seen an increase in the number of people affected by the disease. There are almost 5.5 million Americans living with Alzheimer’s in the United States today, and globally, that number is upwards of about 30 million,” Maria Carrillo, Ph.D., chief science officer at the Alzheimer’s Association (ALZ) tells FOX Business. This week, The Alzheimer’s Association International Conference will kick off in London, England, where the world’s best doctors, researchers, and

Chemotherapy before breast cancer surgery might fuel metastasis

hen breast cancer patients get chemotherapy before surgery to remove their tumor, it can make remaining malignant cells spread to distant sites, resulting in incurable metastatic cancer, scientists reported last week. The main goal of pre-operative (neoadjuvant) chemotherapy for breast cancer is to shrink tumors so women can have a lumpectomy rather than a more invasive mastectomy. It was therefore initially used only on large tumors after being introduced about 25 years ago. But as fewer and fewer women were diagnosed with large breast tumors, pre-op chemo began to be used in patients with smaller cancers, too, in the hope that it would extend survival. But pre-op chemo can, instead, promot

New clues about the link between poor sleep and Alzheimer's

Researchers may have pinpointed the reason why poor sleep has been linked to a higher risk of Alzheimer's disease. The new study found that just one night of sleep disruption led to an increase in a protein called amyloid beta, while a week of sleep disturbance led to increased levels of a protein called tau. Both proteins are connected with Alzheimer's disease. "We showed that poor sleep is associated with higher levels of two Alzheimer's-associated proteins," said senior author Dr. David Holtzman. He is a professor and head of the department of neurology at Washington University School of Medicine in St. Louis. To read the full article, click HERE. Article written by ROBERT PREIDT for CBS

Featured Posts
Recent Posts
Archive
Search By Tags
RSS Feed
  • Facebook - White Circle
  • Twitter - White Circle
  • Instagram - White Circle
  • LinkedIn - White Circle

Connect with us on social media

© 2020 Care For A Cure, Inc. is a non-profit organization

with a 501(c)(3) tax exempt status. All rights reserved.